Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

CD2_BENIGN_LIPO_SKIN_NOS

brain neoplasm: A neoplasm (disease) that involves the brain.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D17.3& Cause of death: ICD-10 — D17.3& 2 out of 7 registries used, show all original rules.	293
4. Check minimum number of events None	293
5. Include endpoints None	293
6. Filter based on genotype QC (FinnGen only)	263

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D17
Name in latin: Neoplasma benignum lipomatosum cutis sive textus subcutanei locis aliis sive non specificatis

NAME	CD2_BENIGN_LIPO_SKIN_NOS
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D173
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D173
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	1781	992	781
Only index persons	1694	957	737
Unadjusted period prevalence (%)
Whole population	0.03	0.03	0.02
Only index persons	0.03	0.04	0.03
Median age at first event (years)
Whole population	52.02	53.10	50.59
Only index persons	51.49	52.86	49.72

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	263	165	98
Unadjusted period prevalence (%)	0.05	0.06	0.04
Median age at first event (years)	53.56	51.75	56.62

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
273: Matched controls
2730

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D17.3

ICD-10 Finland

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

4503599627370496.0

307.7

272

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

11.0

64.2

101

D17.1

ICD-10 Finland

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

10.2

36.8

D17.2

ICD-10 Finland

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

12.8

31.5

D17.9

ICD-10 Finland

Benign lipomatous neoplasm, unspecified

30.4

19.1

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

7.5

17.3

QXE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in uspecified region

21.5

14.0

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

11.8

12.8

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

9.2

11.3

ZXE00

NOMESCO Finland

One hour or less

2.3

9.9

129

773

ZXD10

NOMESCO Finland

Scheduled procedure

2.2

9.1

123

741

R4110

NOMESCO Finland

Physiotherapy

2.3

9.1

547

R22.2

ICD-10 Finland

Localized swelling, mass and lump, trunk

4.9

8.5

D17.7

ICD-10 Finland

Benign lipomatous neoplasm of other sites

92.8

8.5

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

4.4

8.2

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

2.3

8.1

378

Z2221

NOMESCO Finland

Medical doctor

2.2

7.8

519

S04

ICPC

Lump/swelling localized

2.8

7.6

168

TQW99

NOMESCO Finland

Other minor procedure on skin

3.5

7.2

D17.0

ICD-10 Finland

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

9.2

7.1

Z3226

NOMESCO Finland

Physiotherapist

2.3

7.1

323

XLA10, ,

NOMESCO Finland

4.2

7.0

ZXA05

NOMESCO Finland

Left side

2.1

6.9

462

Z71.8

ICD-10 Finland

Other specified counselling

2.0

6.8

111

700

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

2.0

6.7

100

611

QDE99

NOMESCO Finland

Other excision or repair of lesion of skin of lower limb

23.2

6.7

R07.0

ICD-10 Finland

Pain in throat

3.2

6.5

L72.1

ICD-10 Finland

Trichilemmal cyst

3.1

6.5

M16

ICD-10 Finland

Coxarthrosis [arthrosis of hip]

3.3

6.2

S18

ICPC

Laceration/cut

1.9

6.0

143

1011

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3002256) Pathology report gross observation

337

2.17

6.35

1.5

1.3

—

(40768804) Tissue Pathology biopsy report

140

999

1.82

5.59

2.4

2.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

264

2414

3.84

5.50

18.7

18.6

3.93

3.97

mmol/l

1.89

259

2367

(3020564) Creatinine [Moles/volume] in Serum or Plasma

268

2498

4.98

5.00

22.3

20.7

77.27

76.79

umol/l

0.12

263

2466

(40768797) Stomach Pathology biopsy report

362

1.92

4.54

1.2

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

250

2230

2.44

4.24

5.9

5.5

1.81

1.89

mu/l

0.58

238

2064

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

142

1073

1.67

4.23

2.4

2.1

101.15

96.79

pmol/l

0.41

542

(3044889) 12 lead EKG panel

207

1736

1.80

4.14

3.7

4.2

—

16836.33

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

263

2411

3.48

4.10

18.4

18.5

139.81

139.70

mmol/l

0.33

258

2368

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

259

2363

2.87

3.91

16.7

15.6

23.62

22.22

mg/l

0.31

212

1917

(3018095) Leukocytes [#/volume] in Urine

125

935

1.62

3.73

3.9

78.90

92.64

e6/l

0.14

665

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

140

1081

1.61

3.64

2.8

2.6

76.27

77.73

nmol/l

0.25

128

979

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

251

2272

2.30

3.60

6.4

6.5

38.83

39.44

mmol/mol

0.59

239

2143

(3013650) Neutrophils [#/volume] in Blood by Automated count

174

1420

1.62

3.56

10.1

10.0

3.95

4.09

e9/l

0.44

147

1215

(3018010) Neutrophils/Leukocytes in Blood

149

1172

1.60

3.55

6.7

5.8

56.82

57.70

0.36

139

1115

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

189

2.04

3.54

3.3

3.8

84.13

78.76

ng/l

0.15

169

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

252

2288

2.32

3.53

17.2

15.5

80.51

80.36

ml/min/173m2

0.04

239

2127

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

265

2491

3.18

3.52

13.2

12.3

25.25

25.88

u/l

0.23

259

2429

(3051651) Icteric interference index of Serum or Plasma

6.30

3.52

3.9

3.1

1.00

0.92

index

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

176

2.06

3.47

1.2

1.3

—

(3002030) Lymphocytes/Leukocytes in Blood

149

1185

1.57

3.30

6.6

6.0

26.65

27.27

0.27

139

1123

(3022096) Basophils/Leukocytes in Blood

146

1156

1.57

3.29

6.6

6.0

0.68

0.67

0.07

134

1077

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

217

1889

1.73

3.29

8.6

8.2

78.57

79.15

u/l

0.05

205

1790

(3024561) Albumin [Mass/volume] in Serum or Plasma

139

1089

1.56

3.28

5.2

4.8

36.26

35.90

g/l

0.32

133

1027

(3031040) Bacteria [#/volume] in Urine by Automated count

189

1593

1.61

3.21

4.5

—

916.43

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

3.36

3.18

1.2

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

3.36

3.18

1.2

1.4

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

225

1986

1.76

3.15

21.7

19.9

13.48

13.67

1.71

225

1972

(3006504) Eosinophils/Leukocytes in Blood

145

1158

1.54

3.07

6.6

6.0

2.88

2.77

0.21

134

1084

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

154

1254

1.52

2.93

6.9

7.2

1.21

mmol/l

0.24

136

1078

(3013115) Eosinophils [#/volume] in Blood

159

1311

1.51

2.80

6.9

6.3

0.19

e9/l

0.08

142

1134

(3019198) Lymphocytes [#/volume] in Blood

157

1297

1.50

2.70

6.6

6.0

1.85

2.02

e9/l

0.79

142

1135

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

4.76

2.61

1.0

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

2.31

2.60

1.2

1.1

—

(3048689) Calprotectin [Mass/mass] in Stool

307

1.68

2.56

3.0

2.4

61.63

120.62

ug/g

2.37

251

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

7.25

2.56

1.0

2.6

—

(42529406) Shigella sp [Presence] in Stool by Culture

2.28

2.53

1.2

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

214

1903

1.58

2.47

4.3

4.5

14.61

14.83

pmol/l

0.65

205

1742

(3019069) Monocytes/Leukocytes in Blood

142

1163

1.46

2.47

6.8

6.0

8.84

8.79

0.07

131

1094

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

190

1650

1.50

2.42

3.2

3.3

43.81

48.88

u/l

0.36

181

1560

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

555

1.51

2.33

1.4

1.7

1.18

1.24

mg/l

0.08

447

(3006315) Basophils [#/volume] in Blood

152

1276

1.43

2.23

6.7

6.0

0.04

e9/l

0.85

134

1081

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

2.17

1.3

1.1

—

(4146454) Self-monitoring of blood glucose

3.75

2.16

1.6

2.9

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

132

1.90

2.11

1.3

—

(3001604) Monocytes [#/volume] in Blood

151

1274

1.41

2.11

6.7

5.9

0.59

0.58

e9/l

0.28

133

1080

(3044640) Blood type and Crossmatch panel - Blood

778

1.43

2.06

2.5

2.3

—

(3018418) pH of Serum or Plasma

102

806

1.42

2.06

4.8

3.9

7.40

0.27

566

(3013826) Glucose [Moles/volume] in Serum or Plasma

165

1423

1.40

1.98

4.8

5.0

6.80

6.64

mmol/l

0.32

152

1355

(3015377) Calcium [Moles/volume] in Serum or Plasma

110

887

1.40

1.96

4.5

3.4

2.38

2.35

mmol/l

1.09

101

816

(3023183) Ammonium ion [Moles/volume] in Plasma

2.45

1.87

1.5

3.5

24.73

37.61

umol/l

1.68

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

251

2361

1.78

1.86

5.1

5.3

4.67

4.69

mmol/l

0.15

237

2202

(3022145) Colonoscopy Study observation

299

1.56

1.86

1.4

1.3

—

(40768443) Skin Pathology biopsy report

109

1.90

1.83

1.2

—

(1002224) Polysomnography panel

139

1.80

1.82

1.2

1.1

—

(4035726) Immunohistochemistry procedure

226

1.63

1.82

1.3

1.4

—

(3030467) Casts [#/volume] in Urine by Automated count

719

1.40

1.80

3.2

3.1

0.25

0.42

e6/l

0.77

517

(42870588) Differential panel, method unspecified - Blood

103

833

1.38

1.77

7.0

5.7

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

164

1.72

1.76

1.7

3.6

121.62

174.93

ng/l

0.77

148

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

2.97

1.73

1.3

1.1

—

(3000494) Fungus identified in Specimen by Culture

313

1.52

1.72

1.3

1.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

253

2394

1.78

1.70

6.3

6.1

2.73

mmol/l

0.00

239

2225

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

135

1145

1.35

1.70

6.2

6.3

1.21

mmol/l

0.08

125

1048

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

524

1.42

1.70

3.7

2.8

2.47

2.46

mmol/l

0.63

472

(40761511) CBC panel - Blood by Automated count

256

2431

1.85

1.69

12.1

14.0

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

624

1.40

1.69

2.1

2.34

2.88

mg/l

1.43

540

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

392

1.47

1.68

3.4

3.0

3.03

2.48

e6/l

0.15

171

(3025130) Human papilloma virus identified in Specimen

2.49

1.66

1.3

1.8

—

(3019309) Folate [Moles/volume] in Red Blood Cells

412

1.45

1.63

1.6

1.7

908.21

1218.51

nmol/l

1.96

309

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

246

2318

1.62

1.59

5.4

5.3

5.98

5.95

mmol/l

0.12

229

2144

(3025018) Bordetella pertussis Ab [Titer] in Serum

3.04

1.59

1.0

1.3

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

356

1.46

1.52

5.0

7.1

105.18

104.20

mmol/l

0.83

356

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

2.90

1.51

1.2

1.0

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

306

1.48

3.6

3.0

8.61

7.51

umol/l

0.13

275

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

2.76

1.44

1.0

1.1

—

8.28

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

2.76

1.44

1.2

1.1

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

207

1.56

1.43

1.5

1.4

—

(3019977) pH of Arterial blood

283

1.48

1.42

4.8

8.3

7.42

7.41

0.15

163

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

414

1.41

1.42

1.6

1.5

—

(40758558) Short blood count panel - Blood

753

1.33

1.42

8.9

6.4

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

772

1.33

1.42

2.7

3.2

1497.31

1164.14

ng/l

0.26

657

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

560

1.36

1.39

4.5

21.20

22.15

0.23

270

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

217

1.54

1.38

1.6

1.9

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

260

1.49

1.36

2.0

2.4

26.26

29.04

u/l

0.50

217

(3021589) Normoblasts [#/volume] in Blood

130

1122

1.30

1.36

10.3

11.5

0.00

e9/l

0.61

109

912

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

436

1.39

1.34

3.3

2.8

0.72

0.97

e6/l

0.48

216

(3002582) Erythrocytes [#/volume] in Urine

100

834

1.31

1.34

3.3

3.2

43.86

114.67

e6/l

0.42

630

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

2.03

1.24

1.7

1.9

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

141

1.61

1.21

2.9

8.9

17.87

15.93

3.75

136

(3035350) Ketones [Presence] in Urine by Test strip

150

1334

1.28

1.19

3.4

3.8

41.93

11.91

estimate

0.31

294

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

2.34

1.19

1.2

1.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

2.08

1.16

1.3

1.6

—

(3029937) Albumin [Presence] in Urine by Test strip

765

0.75

1.15

3.2

3.8

0.00

estimate

-0.00

271

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

128

1121

1.27

1.14

2.4

2.7

—

estimate

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

431

1.35

1.12

3.5

3.2

0.61

0.75

ug/l

1.41

285

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

487

1.33

1.10

3.6

4.0

1024.78

289.45

ng/l

0.33

379

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

200

1854

1.29

1.09

3.9

4.4

10.20

11.97

mm/h

1.20

184

1722

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1.90

1.09

1.3

1.2

—

(3022948) Iron [Moles/volume] in Serum or Plasma

426

1.33

1.06

2.1

2.4

14.85

13.38

umol/l

0.69

397

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

212

0.59

1.03

2.7

2.9

71.50

61.81

ml/min/173m2

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

131

0.52

1.02

1.3

1.4

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

2.03

1.00

1.4

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

237

2258

1.38

1.00

4.2

4.4

1.37

1.29

mmol/l

0.92

221

2077

(3032080) INR in Blood by Coagulation assay

129

1145

1.24

0.99

13.0

11.7

1.32

1.21

inr

1.18

104

941

(3008295) Osmolality of Serum or Plasma

0.00

0.98

0.0

1.2

—

271.14

—

(3003396) Base excess in Arterial blood by calculation

279

1.38

0.97

5.1

8.4

0.32

1.02

mmol/l

0.85

236

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

290

0.67

0.96

6.1

7.1

—

(3023368) Bacteria identified in Blood by Culture

665

1.26

0.96

3.2

4.3

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

131

1168

1.23

0.95

3.2

3.0

104.25

121.28

ug/l

0.91

121

1089

(3044941) Cell count panel - Synovial fluid

1.91

0.94

1.0

1.3

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

704

1.26

0.94

6.1

5.5

1.59

2.39

ug/l

1.02

631

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

2.25

0.94

1.2

1.0

—

(3026782) Osmolality of Urine

480

1.29

0.94

2.6

2.9

566.23

527.79

mosm/kgh2o

0.69

420

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1.76

0.93

1.2

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

102

1.60

0.92

2.4

4.5

0.92

0.88

0.17

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

118

1044

1.23

0.91

1.9

2.0

1.29

1.37

mmol/l

0.69

111

878

(3015736) pH of Urine

118

1044

1.23

0.91

3.1

3.4

6.16

6.22

0.20

604

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

245

2354

1.40

0.90

5.2

1.45

1.49

mmol/l

0.76

231

2182

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

2.09

0.90

1.0

1.1

—

(40761536) Microorganisms panel - Urine sediment

203

0.62

0.88

3.0

3.8

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

2.02

0.87

1.3

1.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

578

1.26

0.87

2.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

198

1.40

0.84

1.4

1.8

—

(3021960) Folate [Moles/volume] in Serum or Plasma

734

1.23

0.82

1.7

17.70

21.54

nmol/l

2.29

615

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

114

1.52

0.81

1.8

1.9

—

(3019150) Specific gravity of Urine by Refractometry

586

0.78

0.81

2.6

3.8

1.02

kg/l

0.45

388

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

306

1.32

0.81

1.5

1.9

—

(3021601) Nitrite [Presence] in Urine by Test strip

145

1322

1.21

0.80

3.3

3.7

0.00

estimate

-0.00

288

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1.61

0.79

1.6

1.3

250.00

324.65

ug/g

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

408

1.28

0.78

1.4

2.0

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

0.78

0.0

3.9

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.78

0.77

1.3

1.2

—

(3007853) Bacteria identified in Skin by Aerobe culture

273

1.32

0.76

1.6

1.7

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1019

0.83

0.76

3.4

3.6

0.00

estimate

-0.00

238

(3009261) Glucose [Presence] in Urine by Test strip

147

1348

1.20

0.75

3.4

3.8

0.00

1.12

estimate

0.50

269

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

117

1.48

0.73

2.4

4.2

1.56

1.58

0.04

110

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

2.02

0.73

1.0

1.2

—

(3005570) Glucose [Moles/volume] in Urine

2.02

0.73

1.6

2.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1.61

0.73

1.2

1.4

—

(3045424) Erythrocytes [Presence] in Urine

126

1.46

0.72

2.4

2.2

0.00

0.03

estimate

—

(4034850) Laboratory test

0.53

0.68

9.8

10.4

—

(1761868) Lipid panel - Serum or Plasma

977

0.84

0.66

3.1

3.3

—

(3044290) Cell count panel - Cerebral spinal fluid

1.61

0.65

1.1

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

789

1.19

0.65

2.3

2.1

212.82

191.58

u/l

0.11

752

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

290

1.28

0.64

1.6

1.9

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

0.00

0.60

0.0

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1.55

0.60

1.5

1.3

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

0.00

0.59

0.0

1.1

—

37.34

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.59

0.0

1.0

—

595.36

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

0.00

0.59

0.0

1.0

—

269.46

—

(4024509) Urine culture

112

0.62

0.59

1.6

1.9

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

167

1.35

0.59

1.9

1.6

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

0.00

0.58

0.0

1.8

—

532.35

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1.50

0.58

1.3

2.0

—

(3000764) Benzodiazepines [Presence] in Urine

1.53

0.57

1.3

—

(3021788) Differential panel - Synovial fluid

1.68

0.57

1.0

1.4

—

(3000991) Gas panel - Venous blood

214

1.29

0.55

6.3

8.7

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

158

1482

1.16

0.55

3.2

3.0

—

(3027945) Reticulocytes/Erythrocytes in Blood

307

1.24

0.53

2.7

2.9

1.83

1.77

0.14

275

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1.42

0.52

1.0

1.2

—

(3000492) Spirometry study

236

1.26

0.49

1.4

1.5

—

(3037121) Protein [Mass/volume] in Urine

1.47

0.49

2.5

3.7

230.40

208.39

mg/l

—

(3027008) Opiates [Presence] in Urine

1.47

0.49

1.3

—

(3027944) Amphetamines [Presence] in Urine

1.47

0.49

1.3

—

(3028300) Cannabinoids [Presence] in Urine

1.47

0.49

1.3

—

(3011288) Drugs identified in Urine by Screen method Nominal

1.54

0.48

1.3

1.4

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1.47

0.47

1.0

1.3

—

(3042936) Bacteria identified in Isolate by Culture

350

0.81

0.46

1.8

1.9

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.61

0.46

1.0

1.1

—

0.52

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1.38

0.44

1.0

1.3

—

(3023520) Reticulocytes [#/volume] in Blood

240

1.23

0.43

2.5

2.9

76.09

69.40

e9/l

0.72

184

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

1.62

0.43

7.2

3.8

58.80

71.80

u/ml

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1.44

0.43

1.1

3.25

5.87

e6/l

—

(3019225) pH of Specimen

213

1.24

0.42

3.9

4.3

7.41

7.35

2.16

144

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1.42

0.42

1.1

1.2

0.75

230.43

e6/l

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

1.39

0.42

1.3

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

1.52

0.41

1.4

1.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

141

1.30

0.41

1.4

1.8

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.4

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

11.9

—

1086.28

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.00

0.40

0.0

3.3

—

1.17

—

(3016879) Cocaine [Presence] in Urine

1.42

0.40

1.3

—

(21494755) Public health laboratory ask at order entry panel

225

0.79

0.39

1.4

1.5

—

(3028707) Methadone [Presence] in Urine by Screen method

1.44

0.39

1.4

1.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.39

0.0

1.5

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

0.00

0.39

0.0

1.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1.38

0.39

1.4

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

136

0.73

0.38

1.4

1.7

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

134

1.29

0.38

1.1

1.0

—

(3023419) Bacteria identified in Sputum by Culture

1.36

0.37

1.4

2.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

392

0.85

0.35

1.7

1.8

—

(3028026) IgM [Mass/volume] in Serum or Plasma

167

0.77

0.35

1.2

1.7

1.56

1.45

g/l

0.09

153

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1.38

0.35

1.3

1.5

369.72

235.98

miu/ml

—

(3037522) Nuclear Ab [Titer] in Serum

360

1.16

0.35

1.3

720.00

561.86

titre

—

(3009508) Creatinine [Moles/volume] in Urine

865

1.11

0.34

3.4

3.2

7.50

7.68

mmol/l

0.13

725

(3021447) Carbon dioxide [Partial pressure] in Venous blood

248

1.19

0.33

3.7

3.3

5.83

5.68

kpa

0.73

242

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

336

0.85

0.32

1.7

1.6

—

(3005322) IgE [Units/volume] in Serum or Plasma

174

1.22

0.32

1.1

1.2

109.90

419.11

u/ml

1.12

158

(3039000) Anion gap in Blood by calculation

1.28

0.32

3.3

6.7

11.17

10.81

mmol/l

—

(3018572) Chloride [Moles/volume] in Blood

1.28

0.32

3.3

6.7

105.33

104.74

mmol/l

—

(3000850) Epithelial cells [#/volume] in Urine

576

1.12

0.31

2.3

2.6

4.84

6.12

e6/l

0.32

526

(3019832) Treponema pallidum Ab [Presence] in Serum

166

1.22

0.31

1.4

1.7

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

280

0.84

0.29

1.6

—

(3007164) IgA [Mass/volume] in Serum or Plasma

539

0.89

0.28

1.3

1.4

2.33

2.43

g/l

0.22

315

(3047181) Lactate [Moles/volume] in Blood

1.24

0.27

3.6

6.4

0.89

1.19

mmol/l

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

416

1.13

0.27

1.5

1.4

—

(3022621) pH of Urine by Test strip

213

0.83

0.26

2.9

2.2

5.95

6.06

0.19

133

(3015171) Extractable nuclear Ab [Units/volume] in Serum

105

1.25

0.25

1.3

1.2

—

3.07

—

(3041096) Erythrocytes [Presence] in Urine by Automated

740

0.91

0.25

3.7

3.2

0.00

0.11

estimate

0.52

235

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

137

0.79

0.25

1.7

2.4

1.18

1.21

0.07

137

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1.17

0.24

1.3

1.7

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.70

0.24

1.2

1.1

1.55

1.57

g/l

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

143

1.20

0.24

4.5

3.5

4.56

4.49

pmol/l

0.14

125

(3002173) Hemoglobin [Mass/volume] in Arterial blood

247

1.15

0.23

6.0

8.9

126.61

120.09

g/l

1.16

242

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1.25

0.23

2.3

1.6

0.13

0.34

mg/l

—

(3026493) Urate [Moles/volume] in Serum or Plasma

655

1.09

0.23

2.8

347.15

340.73

umol/l

0.21

576

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

0.76

0.23

1.3

—

1.42

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

135

0.81

0.22

1.7

2.4

0.51

0.60

0.62

135

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1.22

0.22

1.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.23

0.21

1.6

1.8

—

(3019060) Gas panel - Arterial blood

145

0.82

0.21

4.3

5.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

0.00

0.21

0.0

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.00

0.21

0.0

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

0.00

0.21

0.0

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

0.00

0.21

0.0

1.5

—

(3020650) Glucose [Presence] in Urine

0.00

0.21

0.0

1.4

—

0.00

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

0.00

0.21

0.0

1.7

—

7.07

—

(40765096) Chromosome analysis panel by Banding

0.00

0.21

0.0

1.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

0.00

0.21

0.0

1.8

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

0.00

0.21

0.0

1.8

—

(44813793) Dust mix specific IgE antibody measurement

0.00

0.21

0.0

1.0

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

805

1.08

0.21

2.2

2.5

54.13

69.35

u/l

1.13

750

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.25

0.21

1.0

1.2

—

(3002032) Base excess in Venous blood by calculation

240

1.14

0.21

3.8

3.2

1.66

1.97

mmol/l

0.21

206

(3012565) Volume of 24 hour Urine

0.00

0.21

0.0

2.7

—

2076.54

—

(3020874) Milk IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

0.11

—

(3006270) Folate [Moles/volume] in Blood

0.00

0.20

0.0

1.2

—

422.21

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

0.00

0.20

0.0

1.1

—

9.64

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.20

0.0

1.4

—

(3020891) Body temperature

122

0.81

0.19

4.3

4.6

37.10

36.96

°c

—

122

(40760892) CBC W Ordered Manual Differential panel - Blood

568

0.92

0.19

3.2

5.0

—

(3025941) Bacteria identified in Stool by Culture

137

1.18

0.19

1.3

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

289

0.89

0.18

6.0

5.0

31.18

32.23

0.28

183

(3004588) Protein electrophoresis panel - Serum or Plasma

174

0.85

0.18

4.5

2.6

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

195

1.14

0.18

1.5

2.4

2.22

7.76

ug/l

3.28

177

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

950

1.07

0.17

3.2

3.9

17.38

27.84

ng/l

3.33

682

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

0.75

0.17

1.4

1.6

—

(3002179) Metamyelocytes/Leukocytes in Blood

204

0.87

0.17

3.9

4.5

0.67

0.56

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1.15

0.16

1.3

1.1

—

5.35

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1.13

0.16

3.4

1.6

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1.09

0.15

2.2

2.5

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

0.80

0.15

1.3

—

2.24

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

0.80

0.15

1.3

—

2.85

—

(3049717) Cytology report of Urine Cyto stain

0.79

0.14

1.7

2.9

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.78

0.14

1.1

1.2

1.01

0.88

g/l

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

112

1.17

0.14

1.5

2.2

1.74

1.57

g/l

0.46

102

(3025159) Blasts/Leukocytes in Blood

212

0.89

0.14

4.8

5.0

0.00

0.19

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

267

1.10

0.13

1.5

1.6

—

(3017181) Myelocytes/Leukocytes in Blood

220

0.90

0.12

3.8

4.4

0.86

1.04

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

1.14

0.10

2.2

2.0

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1.05

0.08

1.3

1.5

—

(3020682) Albumin/Creatinine [Ratio] in Urine

847

1.04

0.08

4.5

3.9

25.20

7.71

mg/mmol

0.60

522

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.82

0.08

1.6

1.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

0.87

0.07

1.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

0.88

0.07

2.5

1.5

—

(3021440) Promyelocytes/Leukocytes in Blood

203

0.93

0.06

3.9

4.6

0.17

0.18

—

(3024354) Oxygen [Partial pressure] in Venous blood

211

0.94

0.04

2.4

2.7

4.21

4.35

kpa

0.14

205

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

231

0.95

0.04

1.6

1.5

—

(3036489) Thrombin time

101

1.09

0.04

1.5

1.8

23.91

20.86

0.25

(3003694) ABO and Rh group [Type] in Blood

668

1.02

0.03

1.3

1.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

171

1.06

0.03

1.3

1.5

—

(36660697) Celiac disease serology panel - Serum

219

0.96

0.03

1.3

1.2

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

611

1.02

0.02

1.3

0.60

1.17

u/ml

1.40

175

(3012516) Albumin [Mass/volume] in Urine

827

0.99

0.01

3.8

3.3

195.59

45.07

mg/l

0.66

538

(3022313) Gas panel - Capillary blood

106

0.94

0.01

2.4

3.7

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

124

1.05

0.00

1.9

3.7

1.97

1.99

mmol/l

—

(3012544) pH of Venous blood

254

1.03

0.00

4.0

3.2

7.39

0.17

145

(3017732) Neutrophils [#/volume] in Blood

314

1.02

0.00

2.5

3.2

3.62

6.60

e9/l

0.97

271

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

506

0.99

0.00

1.6

1.7

399.88

457.91

pmol/l

1.35

425

(3026008) Bacteria identified in Urine by Culture

748

1.00

0.00

3.6

3.0

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

125

1.04

0.00

2.8

2.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

455

0.99

0.00

1.4

1.3

1.38

6.71

u/ml

2.64

172

(3008152) Bicarbonate [Moles/volume] in Arterial blood

156

1.03

0.00

5.0

7.3

24.15

24.56

mmol/l

0.38

150

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

514

0.99

0.00

1.5

1.3

11.10

29.24

iu/ml

—

161

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

244

0.98

0.00

2.4

3.7

—

(3009343) pH of Capillary blood

154

0.97

0.00

2.1

3.5

7.42

—

125

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1.01

0.00

1.3

1.7

—

(3006576) Bicarbonate [Moles/volume] in Blood

0.00

-0.00

0.0

5.2

—

25.86

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

0.00

-0.00

0.0

1.2

—

(3011544) Albumin [Mass/volume] in Pleural fluid

0.00

-0.00

0.0

1.0

—

18.12

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

38.67

—

(3035933) Granulocytes/Leukocytes in Blood

0.92

-0.00

2.2

2.6

47.60

61.09

—

(3011436) Histone Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

0.00

-0.00

0.0

1.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

0.00

-0.00

0.0

1.2

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

-0.00

0.0

1.8

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.2

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.4

—

1.91

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

0.97

-0.00

1.3

1.2

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

(3022689) Creatine [Moles/volume] in Urine

0.00

-0.00

0.0

1.6

—

9.05

—

(3012501) Base excess in Blood by calculation

0.96

-0.00

3.0

2.3

2.80

2.50

mmol/l

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

0.00

-0.00

0.0

1.3

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

2.8

—

(1761482) Bacteria [#/volume] in Urine by Culture

1.02

-0.00

8.7

4.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

57.60

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.6

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

1.31

—

(3008898) HLA-B27 [Presence]

0.92

-0.00

1.0

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.3

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

0.96

-0.00

1.2

1.1

3.52

3.86

mmol/l

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.96

-0.00

1.4

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.00

-0.00

0.0

1.0

—

(40768793) Breast Pathology biopsy report

1.01

-0.00

1.3

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

2.8

—

(3034426) Prothrombin time (PT)

0.00

-0.00

0.0

1.2

—

28.89

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

33.64

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.1

—

(3045414) Leukocytes [Presence] in Urine

240

1.00

-0.00

2.3

2.1

0.00

0.06

estimate

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

0.99

-0.00

1.0

1.3

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

0.00

-0.00

0.0

2.7

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.1

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

0.00

-0.00

0.0

3.6

—

74.71

—

(3013727) Leukocytes other/Leukocytes in Blood

0.00

-0.00

0.0

5.5

—

44.13

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3002619) Bacteria identified in Specimen by Culture

0.00

-0.00

0.0

1.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.02

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.1

—

(40758292) HTLV I+II Ab panel - Serum

0.00

-0.00

0.0

1.7

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.3

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.00

-0.00

0.0

1.3

—

9.60

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

0.89

-0.00

1.1

1.2

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(4211845) Urine protein measurement

0.00

-0.00

0.0

1.0

—

(4094501) Cardiovascular stress test using bicycle ergometer

0.91

-0.00

1.0

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_LIPO_SKIN_NOS and mortality.

Females

Parameter	HR [95% CI]	p-value
CD2_BENIGN_LIPO_SKIN_NOS	0.961 [0.78, 1.19]	0.715
Birth year	0.994 [0.99, 1.0]	0.193

During the follow-up period (1.1.1998 — 31.12.2019), 112 out of 879 females with CD2_BENIGN_LIPO_SKIN_NOS died.

Males

Parameter	HR [95% CI]	p-value
CD2_BENIGN_LIPO_SKIN_NOS	1.001 [0.81, 1.23]	0.993
Birth year	0.986 [0.98, 1.0]	0.003

During the follow-up period (1.1.1998 — 31.12.2019), 103 out of 695 males with CD2_BENIGN_LIPO_SKIN_NOS died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_LIPO_SKIN_NOS.

N-year risk	Females	Males
1	0.086%	0.191%
5	0.541%	1.153%
10	1.358%	2.721%
15	2.642%	5.416%
20	4.742%	9.295%

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_LIPO_SKIN_NOS – Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints